Dr. Myers is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3300 Main Stret
Springfield, MA 01199Phone+1 413-794-5505Fax+1 413-794-7333
Education & Training
- University of Oklahoma Health Sciences CenterFellowship, Gynecologic Oncology, 2006 - 2009
- Temple University HospitalResidency, Obstetrics and Gynecology, 2002 - 2006
- Lewis Katz School of Medicine at Temple UniversityClass of 2002
Certifications & Licensure
- MA State Medical License 2009 - 2026
- OK State Medical License 2006 - 2010
- PA State Medical License 2002 - 2008
- American Board of Internal Medicine Hospice and Palliative Medicine
- American Board of Obstetrics and Gynecology Obstetrics & Gynecology
- American Board of Obstetrics and Gynecology Gynecologic Oncology
Awards, Honors, & Recognition
- Fellow American College of Surgeons, 2018
- Fellow (FACOG) American Congress of Obstetricians and Gynecologists
Clinical Trials
- CA-IX, p16, Proliferative Markers, and HPV in Diagnosing Cervical Lesions in Patients With Abnormal Cervical Cells Start of enrollment: 2009 Apr 13
- Collecting Tumor Samples From Patients With Gynecological Tumors Start of enrollment: 1992 Jun 01
- Lymphedema After Surgery in Patients With Endometrial Cancer, Cervical Cancer, or Vulvar Cancer Start of enrollment: 2012 Jun 01
- Join now to see all
Publications & Presentations
PubMed
- Patient-reported outcomes in the subpopulation of patients with mismatch repair-deficient/microsatellite instability-high primary advanced or recurrent endometrial can...Giorgio Valabrega, Matthew A Powell, Sakari Hietanen, Eirwen M Miller, Zoltan Novak
International Journal of Gynecological Cancer. 2025-01-06 - 3 citationsPhase II Trial of Cisplatin, Gemcitabine, and Intensity-Modulated Radiation Therapy for Locally Advanced Vulvar Squamous Cell Carcinoma: NRG Oncology/GOG Study 279.Neil S Horowitz, Wei Deng, Ivy Peterson, Robert S Mannel, Spencer Thompson
Journal of Clinical Oncology. 2024-06-01 - Maintenance with mirvetuximab soravtansine plus bevacizumab vs bevacizumab in FRα-high platinum-sensitive ovarian cancer.David M O'Malley, Tashanna Myers, Pauline Wimberger, Toon Van Gorp, Andres Redondo
Future Oncology. 2024-01-01
Professional Memberships
- Member
- Society of Gynecologic OncologyMember
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: